| 摘要 |
<P>PROBLEM TO BE SOLVED: To prevent stability reduction of triptane caused by blending an acidulant in a liquid medicine for oral dosing containing triptane. <P>SOLUTION: The liquid medicine for oral dosing is obtained by blending triptane or a pharmacologically acceptable salt thereof, at least one acidulant selected from the group consisting of citric acid, malic acid, tartaric acid, lactic acid, and salts thereof, and further at least one sugar alcohol selected from the group consisting of erythritol, xylitol, sorbitol, and maltitol. <P>COPYRIGHT: (C)2012,JPO&INPIT |
